{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:49:23Z","timestamp":1791521363988,"version":"4.3.4"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Bloodstream infections (BSIs) are associated with a high mortality ratio among critically ill children. BSIs caused by multidrug-resistant (MDR) bacteria are a challenge due to limited therapeutic options. In this multicenter cohort study, factors associated with death of children with bacterial laboratory-confirmed BSI (LC-BSI) admitted to the intensive care unit (ICU) were analyzed, with a focus on MDR bacterial infection and appropriateness of therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective cohort of children \u226418 years of age with LC-BSI, and admitted to 9 ICUs, was conducted from January 1, 2016, to December 31, 2018, in Rio de Janeiro, Brazil. Risk factors of 30- and 7-day death of LC-BSI were identified using multivariable logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Two hundred thirty-eight LC-BSI episodes occurred in 215 patients; 31.1% were caused by MDR bacteria. Inappropriate initial antibiotic therapy and definitive antibiotic therapy were administered in 50.4% and 8.4% of the episodes, respectively. The 30- and 7-day mortality ratios were 18.5% and 8.8%, respectively. Hematologic disease as primary condition, pediatric risk of mortality score \u226520 on date of LC-BSI, use of vasopressors, ICU-acquired BSI and LC-BSI from hospital B were independently associated with 30-day death. Inappropriate definitive antibiotic therapy; infectious disease, congenital heart disease and hematologic disease as primary conditions; PRISM score \u226520 at the time of LC-BSI; use of\/vasopressors and LC-BSI secondary to respiratory tract or intra-abdominal infection were independently associated with 7-day death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Key clinical and healthcare-related factors associated with mortality in LC-BSI were identified.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005290","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:00:38Z","timestamp":1779336038000},"page":"e434-e441","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bacterial Bloodstream Infections in Pediatric Intensive Care Units"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7298-7196","authenticated-orcid":false,"given":"Patr\u00edcia de Oliveira","family":"Costa","sequence":"first","affiliation":[{"name":"Hospital do C\u00e2ncer I, National Institute of Cancer, Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Infection Disease Division, Department of Internal Medicine, Faculty of Medicine, Federal Fluminense University, Niter\u00f3i, Rio de Janeiro, Brazil"},{"name":"Hospital Federal dos Servidores do Estado, Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-1950","authenticated-orcid":false,"given":"Shelley","family":"Ehrlich","sequence":"additional","affiliation":[{"name":"Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3260-2554","authenticated-orcid":false,"given":"Ianick Souto","family":"Martins","sequence":"additional","affiliation":[{"name":"Hospital do C\u00e2ncer I, National Institute of Cancer, Rio de Janeiro, Rio de Janeiro, Brazil"},{"name":"Infection Disease Division, Department of Internal Medicine, Faculty of Medicine, Federal Fluminense University, Niter\u00f3i, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1017\/ice.2019.353","article-title":"Length of stay, cost, and mortality of healthcare-acquired bloodstream infections in children and neonates: a systematic review and meta-analysis.","volume":"41","author":"Karagiannidou","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/20469047.2018.1529459","article-title":"Predictors of mortality in children with nosocomial bloodstream infection.","volume":"39","author":"Murni","year":"2019","journal-title":"Paediatr Int Child Health"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/14656566.2018.1559817","article-title":"The use of polymyxins to treat carbapenem resistant infections in neonates and children.","volume":"20","author":"Thomas","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/microorganisms11071798","article-title":"Novel beta lactam antibiotics for the treatment of multidrug-resistant gram-negative infections in children: a narrative review.","volume":"11","author":"Venuti","year":"2023","journal-title":"Microorganisms"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/antibiotics12020261","article-title":"Therapeutic options and outcomes for the treatment of children with gram-positive bacteria with resistances of concern: a systematic review.","volume":"12","author":"Chiusaroli","year":"2023","journal-title":"Antibiotics"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"e20190205","DOI":"10.1590\/0037-8682-0205-2019","article-title":"Surveillance of multidrug-resistant bacteria in pediatric and neonatal intensive care units in Rio de Janeiro State, Brazil.","volume":"52","author":"Oliveira","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"1382500","DOI":"10.3389\/fcimb.2024.1382500","article-title":"Increased rate of multidrug-resistant gram-negative bacterial infections in hospitalized immunocompromised pediatric patients.","volume":"14","author":"Khafaja","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s15010-015-0857-8","article-title":"Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.","volume":"44","author":"Iv\u00e1dy","year":"2016","journal-title":"Infection"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bjid.2015.12.004","article-title":"Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.","volume":"20","author":"Akturk","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/antibiotics12020405","article-title":"Carbapenem-resistant enterobacteriaceae (CRE) among children with cancer: predictors of mortality and treatment outcome.","volume":"12","author":"Madney","year":"2023","journal-title":"Antibiotics"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s15010-020-01439-y","article-title":"Blood culture sampling rate in hospitalised children as a quality indicator for diagnostic stewardship.","volume":"48","author":"Araujo da Silva","year":"2020","journal-title":"Infection"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/jim-2020-001473","article-title":"Diagnostic accuracy of time to first positivity of blood cultures for predicting severe clinical outcomes in children with pneumonia-related bacteremia.","volume":"68","author":"Zhang","year":"2020","journal-title":"J Investig Med"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/jpids\/piad037","article-title":"The utility of performing anaerobic blood cultures in pediatric intensive care units.","volume":"12","author":"Kato","year":"2023","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R16-20261009","first-page":"81","article-title":"Validation of PRISM III (Pediatric Risk of Mortality) scoring system in predicting risk of mortality in a pediatric intensive care unit.","volume":"17","author":"Popli","journal-title":"IOSR J Dent Med Sci"},{"issue":"10 suppl 2","key":"R22-20261009","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ajic.2007.10.007","article-title":"Management of multidrug-resistant organisms in health care settings, 2006.","volume":"35","author":"Siegel","year":"2007","journal-title":"Am J Infect Control"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/ice.2019.297","article-title":"Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017.","volume":"41","author":"Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ije\/dyw040","article-title":"Outcome modelling strategies in epidemiology: traditional methods and basic alternatives.","volume":"45","author":"Greenland","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhin.2005.06.032","article-title":"Rate, risk factors and outcomes of catheter-related bloodstream infection in a paediatric intensive care unit in Saudi Arabia.","volume":"62","author":"Almuneef","year":"2006","journal-title":"J Hosp Infect"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ajic.2006.09.007","article-title":"Epidemiology of hospital-acquired bloodstream infections in a Tunisian pediatric intensive care unit: a 2-year prospective study.","volume":"35","author":"Jaballah","year":"2007","journal-title":"Am J Infect Control"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/tropej\/fml073","article-title":"Study of nosocomial primary bloodstream infections in a pediatric intensive care unit.","volume":"53","author":"Lakshmi","year":"2007","journal-title":"J Trop Pediatr"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/INF.0b013e3181df6c54","article-title":"Risk factors for catheter-associated bloodstream infections in a pediatric cardiac intensive care unit.","volume":"29","author":"Prasad","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3324\/haematol.2009.020867","article-title":"Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.","volume":"95","author":"Caselli","year":"2010","journal-title":"Haematologica"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/INF.0b013e31828aebc8","article-title":"Antibiotic-resistant gram-negative bacteremia in pediatric oncology patients\u2014risk factors and outcomes.","volume":"32","author":"Haeusler","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-017-2597-0","article-title":"Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPH.0000000000001279","article-title":"Blood stream infections and antibiotic utilization in pediatric leukemia patients with febrile neutropenia.","volume":"41","author":"Reinecke","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s15010-018-1260-z","article-title":"Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.","volume":"47","author":"Bae","year":"2019","journal-title":"Infection"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric febrile neutropenia: change in etiology of bacteremia, empiric choice of therapy and clinical outcomes.","volume":"42","author":"Alali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1089\/mdr.2018.0465","article-title":"Risk factors for mortality in children with Acinetobacter baumannii bacteremia in South Korea: the role of carbapenem resistance.","volume":"25","author":"Choe","year":"2019","journal-title":"Microb Drug Resist (Larchmont, N.Y.)"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3346\/jkms.2011.26.5.612","article-title":"Pseudomonas aeruginosa bacteremia in children over ten consecutive years: analysis of clinical characteristics, risk factors of multi-drug resistance and clinical outcomes.","volume":"26","author":"Yang","year":"2011","journal-title":"J Korean Med Sci"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jac\/dkaa397","article-title":"Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing enterobacteriaceae bloodstream infections in Spanish children.","volume":"76","author":"Ara-Montojo","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"R39-20261009","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-022-03622-6","article-title":"Time to appropriate antimicrobial therapy serves an independent prognostic indicator in children with nosocomial Klebsiella pneumoniae bloodstream infection.","volume":"22","author":"Cheng","year":"2022","journal-title":"BMC Pediatr"},{"key":"R40-20261009","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-018-2099-5","article-title":"Clinical characteristics and prognosis of bacteraemia during postoperative intra-abdominal infections.","volume":"22","author":"Alqarni","year":"2018","journal-title":"Crit Care"},{"key":"R41-20261009","article-title":"Clinical characteristics and prognosis of pneumonia-related bloodstream infections in the intensive care unit: a single-center retrospective study.","volume":"11","author":"Liu","year":"2023","journal-title":"Front Public Health"},{"key":"R42-20261009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.36401\/JQSH-22-4","article-title":"Reducing central-line\u2013associated bloodstream infections (CLABSI): an improvement project in a specialized tertiary hospital.","volume":"5","author":"Mostafa","year":"2022","journal-title":"Glob J Qual Saf Healthc"},{"key":"R43-20261009","doi-asserted-by":"crossref","first-page":"1492208","DOI":"10.3389\/fcimb.2025.1492208","article-title":"Risk factors associated with mortality and pathogen characteristics of bloodstream infection-induced severe sepsis in the pediatric intensive care unit: a retrospective cohort study.","volume":"15","author":"Chen","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"R44-20261009","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/INF.0000000000000339","article-title":"Epidemiology and clinical outcomes of multidrug-resistant, Gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.","volume":"33","author":"Folgori","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R45-20261009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/SHK.0000000000000833","article-title":"Association of delayed antimicrobial therapy with one-year mortality in pediatric sepsis.","volume":"48","author":"Han","year":"2017","journal-title":"Shock"},{"key":"R46-20261009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/INF.0000000000002273","article-title":"Multidrug-resistant gram-negative bacterial bloodstream infections in children\u2019s hospitals in Japan, 2010-2017.","volume":"38","author":"Aizawa","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R47-20261009","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12879-018-3160-3","article-title":"Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients.","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R48-20261009","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00623-19","article-title":"Effects of delayed antibiotic therapy on outcomes in children with Streptococcus pneumoniae sepsis.","volume":"63","author":"Li","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-20261009","first-page":"4709","article-title":"Bacteriological profile and antimicrobial susceptibility pattern of blood culture isolates among septicemia suspected children in selected hospitals addis Ababa, Ethiopia.","volume":"6","author":"Negussie","year":"2015","journal-title":"Int J Biol Med Res"},{"key":"R50-20261009","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0950268810001640","article-title":"Epidemiology and outcome of Gram-negative bloodstream infection in children: a population-based study.","volume":"139","author":"Al-Hasan","year":"2011","journal-title":"Epidemiol Infect"},{"key":"R51-20261009","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3947\/ic.2016.48.3.181","article-title":"Increase in antibiotic-resistant gram-negative bacterial infections in febrile neutropenic children.","volume":"48","author":"Lee","year":"2016","journal-title":"Infect Chemother"},{"key":"R52-20261009","doi-asserted-by":"crossref","DOI":"10.1186\/cc10114","article-title":"Acquired bloodstream infection in the intensive care unit: Incidence and attributable mortality.","volume":"15","author":"Prowle","year":"2011","journal-title":"Crit Care"},{"key":"R53-20261009","doi-asserted-by":"crossref","DOI":"10.1186\/s12960-024-00893-1","article-title":"Effects of intensive care unit quality assessment on changes in medical staff in medical institutions and in-hospital mortality.","volume":"22","author":"Kim","year":"2024","journal-title":"Hum Resour Health"},{"key":"R54-20261009","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00246-018-1908-6","article-title":"Survival and associated risk factors for mortality among infants with critical congenital heart disease in a developing country.","volume":"39","author":"Mat Bah","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"R55-20261009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13052-021-00966-0","article-title":"The epidemiology of hospital death following pediatric severe community acquired pneumonia.","volume":"47","author":"Ao","year":"2021","journal-title":"Ital J Pediatr"},{"key":"R56-20261009","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/INF.0000000000002202","article-title":"Staphylococcus aureus bacteremia in children: antibiotic resistance and mortality.","volume":"38","author":"Gordon","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R57-20261009","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamapediatrics.2021.5177","article-title":"Rates in bronchiolitis hospitalization, intensive care unit use, mortality, and costs from 2004 to 2018.","volume":"176","author":"Mahant","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R58-20261009","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.surg.2019.03.005","article-title":"Necrotizing enterocolitis totalis: high mortality in the absence of an aggressive surgical approach.","volume":"165","author":"Dukleska","year":"2019","journal-title":"Surgery"},{"key":"R59-20261009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17474086.2017.1280389","article-title":"Typhlitis (neutropenic enterocolitis) in patients with acute leukemia: a review.","volume":"10","author":"Portugal","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"R60-20261009","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(20)30477-1","article-title":"Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.","volume":"21","author":"Kadri","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:02:49Z","timestamp":1791518569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005290"}},"subtitle":["A Multicenter Cohort Study to Investigate the Epidemiology and Risk Factors for Mortality"],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005290","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}